Precision BioSciences Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Precision BioSciences Inc. on September 23, 2019. The report discloses a change in executive leadership and associated compensatory arrangements effective August 13, 2019.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on personnel changes and compensation adjustments.
Material Changes
- Executive Promotion: David Thomson, Ph.D., was promoted from Chief Development Officer to Chief Operating Officer, effective August 13, 2019.
- Compensation Adjustment: In connection with the promotion, Dr. Thomson's annual base salary was increased to $415,000.
- Bonus Structure: His target annual bonus opportunity was increased to 40% of his base salary.
Outlook, Risks, and Commentary
The filing contains no financial guidance, market outlook, or discussion of risks and contingencies. It serves strictly to disclose the executive appointment and the specific terms of the new compensatory arrangement.
Investor Verification Points
- Confirm the effective date of the promotion (August 13, 2019) versus the filing date (September 23, 2019).
- Verify the new compensation terms: $415,000 base salary and 40% target bonus.
- Review Dr. Thomson's prior experience at Shire plc and academic roles as disclosed in the filing.